MedTrace Logo

Clinical Feasibility Study of Allium's Biliary Stent

NCT00448006 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-07-10

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and efficacy of the Allium Biliary Stent in malignant obstructions of the common bile duct.

Conditions

  • Malignant Obstruction of the Common Bile Duct

Interventions

DEVICE

Allium Biliary Stent

device

DEVICE

allium biliary stent

allium biliary stent

Sponsors & Collaborators

  • Allium, Ltd.

    lead INDUSTRY

Principal Investigators

  • Simon Bar-Meir, M.D. · Sheba Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00448006 on ClinicalTrials.gov